Leroux, S., Turner, M., Guellec, C., Hill, H., den Anker, J., Kearns, G., Jacqz-Aigrain, E., Zhao, W., Leroux, S., Turner, M. A., Guellec, C. B.-L., van den Anker, J. N., Kearns, G. L., & TINN (Treat Infections in Neo Nates) and GRi P (Global Research in Paediatrics) Consortiums. (2015). Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design. Clinical Pharmacokinetics, 54(12), 1273-1285. https://doi.org/10.1007/s40262-015-0291-1

LEROUX, Stéphanie, TURNER, Mark, GUELLEC, Chantal, HILL, Helen, DEN ANKER, Johannes, KEARNS, Gregory, JACQZ-AIGRAIN, Evelyne, ZHAO, Wei, LEROUX, Stéphanie, TURNER, Mark A, GUELLEC, Chantal Barin-Le, VAN DEN ANKER, Johannes N, KEARNS, Gregory L und TINN (TREAT INFECTIONS IN NEONATES) AND GRIP (GLOBAL RESEARCH IN PAEDIATRICS) CONSORTIUMS, 2015. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design. Clinical Pharmacokinetics. 1 Dezember 2015. Vol. 54, no. 12, p. 1273-1285. DOI 10.1007/s40262-015-0291-1.

Leroux, S., M. Turner, C. Guellec, H. Hill, J. den Anker, G. Kearns, E. Jacqz-Aigrain, W. Zhao, S. Leroux, M. A. Turner, C. B.-L. Guellec, J. N. van den Anker, G. L. Kearns, und TINN (Treat Infections in Neo Nates) and GRi P (Global Research in Paediatrics) Consortiums. „Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.“. Clinical Pharmacokinetics, Bd. 54, Nr. 12, Dezember 2015, S. 1273-85, https://doi.org/10.1007/s40262-015-0291-1.

Leroux, Stéphanie/Turner, Mark/Guellec, Chantal/Hill, Helen/den Anker, Johannes/Kearns, Gregory u. a.: Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design., Clinical Pharmacokinetics 2015, 1273-1285.

Leroux, S., Turner, M., Guellec, C., Hill, H., den Anker, J., Kearns, G., Jacqz-Aigrain, E., Zhao, W., Leroux, S., Turner, M.A., Guellec, C.B.-L., van den Anker, J.N., Kearns, G.L. und TINN (Treat Infections in Neo Nates) and GRi P (Global Research in Paediatrics) Consortiums. (2015), „Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.“, Clinical Pharmacokinetics, Vol. 54 No. 12, S. 1273-1285.